April 2019

On March 26, 2019, Purdue Pharma LP, the manufacturer of OxyContin, together with the Sackler family who own the company, agreed…

Here in the US, there has been a tremendous amount of discussion in recent years about the soaring cost of prescription drugs, and…

According to research funded by the FDA and published last month, participants in a study on direct-to-consumer (DTC) advertising…

On April 9th, the U.S. Department of Justice (DOJ) announced that a federal grand jury returned a 28-count criminal indictment…

On April 18, 2019, President Trump signed H.R. 1839—Medicaid Services Investment and Accountability Act of 2019—into law.  The new…

A new Congressional Budget Office report Prices for and Spending on Specialty Drugs in Medicare Part D and Medicaid finds that net…

Recently the FDA issued final guidance on FDA’s application of the statutory factors in determining when a risk evaluation and…

On April 2, 2019, the Senate Committee on Aging held a hearing to look at innovations being made in Alzheimer’s research and care…

Telemedicine has long been discussed as a possibility of where our healthcare future lies: the ability to log into your computer…

After several years, the Maine Board of Pharmacy issued its Notice of Agency Rule-making Proposal related to its gift ban law that…